BENDHEIM JACK (President and CEO) sold 38.4% of their position (14.08K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $715.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/23/2026ACC: 0001104659-26-018606
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-14.08K
Net shares
Net seller
$715.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
14.08K disposed
Non-Derivative Transactions3
Class A Common Stock
Indirect
Shares
−7.04K
Price / share
$50.26
Trade value
$353.81K
% of position
19.2%
2/19/2026
36.68K→29.64K
Class A Common Stock
Indirect
Shares
−6.64K
Price / share
$51.38
Trade value
$341.34K
% of position
22.4%
2/20/2026
29.64K→23K
Class A Common Stock
Indirect
Shares
−397.00
Price / share
$51.96
Trade value
$20.63K
% of position
1.7%
2/20/2026
23K→22.60K
Total
Net shares
−14.08K
Net value
-$715.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 2/19/2026 | S · Sale | −7.04K | $50.26 | $353.81K | 19.2% | 36.68K | 29.64K |
| Class A Common Stock Indirect | 2/20/2026 | S · Sale | −6.64K | $51.38 | $341.34K | 22.4% | 29.64K | 23K |
| Class A Common Stock Indirect | 2/20/2026 | S · Sale | −397.00 | $51.96 | $20.63K | 1.7% | 23K | 22.60K |
| Total | −14.08K | -$715.78K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
DirectShares owned16.84K
Total
16.84K direct16.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported